GAS5 and hepatocellular carcinoma: Kaplan–Meier survival analysis of the TCGA_LIHC dataset revealed that patients with HCC with high GAS5 expression had a significantly lower 5-year disease-free survival rate compared with those with low GAS5 levels (Fig. 2c).